When should anticoagulation be restarted after a subdural hematoma?

When to Restart Anticoagulation After Subdural Hematoma

For patients with subdural hematoma requiring anticoagulation, restart therapy at 7-10 days after the hemorrhage if thrombotic risk is very high (mechanical heart valves, atrial fibrillation with CHADS₂-VASc ≥4, or recent VTE within 3 months), but wait 4-8 weeks for moderate thrombotic risk, provided the hematoma has stabilized on repeat imaging. 1, 2

Immediate Management

• Discontinue all anticoagulants immediately upon diagnosis of subdural hematoma 1
• Reverse anticoagulation urgently using appropriate agents:
  • Warfarin: prothrombin complex concentrate (PCC) plus vitamin K 1
  • Fresh frozen plasma if PCC unavailable 1
  • Protamine for heparin-related hemorrhage 1
• Hold anticoagulation for at least 1-2 weeks during the acute period to prevent hematoma expansion 1

Risk Stratification for Restart Timing

Very High Thrombotic Risk (Restart at 7-10 Days)

Restart anticoagulation at 7-10 days after confirming hemorrhage stability on repeat CT/MRI for: 1, 2

• Mechanical heart valves (especially mitral position or caged-ball/tilting disc prostheses) 1, 2
• Atrial fibrillation with CHADS₂-VASc score ≥4 1, 2
• Venous thromboembolism within the past 3 months 1, 2
• Prior stroke/TIA within 3 months 1
• Left ventricular or left atrial thrombus 1

Rationale: Mechanical valves carry ≥4% per year thromboembolism risk when off anticoagulation, and retrospective data show only 0.8% rebleeding rate with restart at 7-10 days versus 5% thromboembolic rate when therapy is held 2

Moderate Thrombotic Risk (Restart at 4-8 Weeks)

Wait 4-8 weeks before restarting for: 2

• Atrial fibrillation with CHADS₂-VASc score 2-3 2
• Remote venous thromboembolism >3 months ago 2
• Bioprosthetic valve >3 months post-placement 1

Do Not Restart Anticoagulation

Permanently discontinue anticoagulation for: 1

• Nonvalvular atrial fibrillation with CHADS₂-VASc <2 (men) or <3 (women) 1
• Temporary indications (post-surgical prophylaxis, post-MI without LV thrombus) 1
• First-time provoked VTE >3 months ago 1

Pre-Restart Requirements

Mandatory Imaging Confirmation

• Obtain repeat CT or MRI before restarting to verify hematoma stability or resolution 1, 2
• No patient with initial SDH ≤3 mm required surgery in follow-up, though 11% enlarged to maximum 10 mm 3
• Evaluate for microbleeds on MRI if available; presence increases ICH risk on anticoagulation to 9.3% versus 1.3% without microbleeds 2

Blood Pressure Control

• Achieve systolic BP <130/80 mmHg before restarting anticoagulation 2
• Uncontrolled hypertension markedly increases bleeding risk on oral anticoagulants 2

High-Risk Situations Requiring Delay or Alternative Strategies

Delay Restart If:

• Lobar location of subdural hematoma (suggests possible cerebral amyloid angiopathy with higher rebleeding risk) 1, 2
• Elderly patients with lobar hemorrhage 1
• Multiple microbleeds on gradient-echo MRI 2
• Very poor overall neurological function 1
• Source of bleeding not yet identified 1
• Surgical/invasive procedure planned 1

Alternative Strategies for High Rebleeding Risk:

• Consider left atrial appendage closure instead of anticoagulation for atrial fibrillation patients 4
• Use antiplatelet monotherapy (aspirin) for patients with lobar ICH or suspected amyloid angiopathy 2
• Aspirin is generally safe after ICH and may be restarted >24 hours after symptom onset 2

Anticoagulant Selection

• Direct oral anticoagulants (DOACs) are preferred over warfarin for atrial fibrillation due to lower intracerebral hemorrhage risk 2
• Avoid heparin "bridging" when initiating DOACs; bridging increases bleeding without added thrombotic protection 4, 2
• For very high thrombotic risk requiring immediate anticoagulation, use unfractionated heparin IV infusion (short half-life, reversible with protamine) with close monitoring 1

Special Considerations for Chronic Subdural Hematoma

Post-Surgical Management

• Restarting anticoagulation 7-14 days after burr-hole drainage does not increase recurrence rates compared to non-anticoagulated patients 5, 6
• Early warfarin resumption within 2-3 days post-surgery (targeting INR 2.1) showed no increased recurrence in matched cohort (11% vs 12% in ordinary patients) 6
• Patients with middle meningeal artery embolization (MMAE) plus surgery who received early anticoagulation had significantly lower mortality (7.9% vs 19.4%) and reduced repeat hemorrhage (54.0% vs 66.9%) compared to surgery alone 7

Risk of Delayed Restart

• Thromboembolic complications occurred in 8% of anticoagulated AF patients after CSDH surgery, with 70% having unfavorable outcomes versus 21% without complications 8
• Median restart time of approximately 1 month was associated with elevated thrombotic/thromboembolic events but not unplanned hematoma evacuation 9
• One study reported 1.1% atrial clot formation when anticoagulation held median 67 days 10

Residual Hematoma Warning

• If residual SDH present at restart, 41.2% suffered rebleeding and 17.6% required surgery 10
• Risk climbed to 62.5% rebleeding if residual SDH was large 10
• Wait until complete resolution for 82.1% of patients in one series 10

Hemorrhagic Transformation Exception

• For hemorrhagic transformation of ischemic stroke (not primary ICH), anticoagulation may be continued depending on clinical scenario and underlying indication 1

Common Pitfalls

• Do not wait for complete hematoma resolution in very high thrombotic risk patients; 7-10 day restart is supported by evidence showing greater thromboembolic than bleeding risk 2
• Do not use combination OAC plus antiplatelet after TIA or stroke 2
• Do not restart anticoagulation without repeat imaging to confirm stability 1, 2
• Do not ignore blood pressure control; achieve target <130/80 mmHg before restart 2